On 19 Oct 2026, HANSOH PHARMA (03692.HK) signed an ADC licensing deal with Roche, with US$400mn upfront, US$110mn a year later and over US$15bn milestones.
On October 11, YUNFENG FIN (00376.HK) published a supplemental announcement disclosing that Yunfeng Financial Markets Limited, the disposal target, recorded an after-tax loss of HKD263.4 million in 2025, and setting out the basis for determining the preliminary consideration of HKD8.05 million. The shares closed at HKD2.070 on October 16, with southbound holdings of 37.158 million shares, or 0.91% of shares in issue.
Hong Kong indices fell this week, with the HSI down 0.10% and the HSTECH down 2.13%, as southbound capital recorded a net outflow of HK$6.637 billion overall.
RoboSense (02498.HK) closed at HKD 14.780 on Oct 16, up 1.23%. Three founders' stakes are held in trust by TMF (Cayman) Ltd., totalling 101.93 million shares.
Nissin Foods (01475.HK) left Stock Connect on September 7, closing at HKD 6.235 on Oct 16, down 34.6% from the 52-week high; H1 net profit up 2.1% year on year.
The lock-up on 1,180,000 H shares held by two cornerstone investors of EXTREME VISION (06636.HK), 9.46% of the offer shares, expires on December 31, 2026.
On 16 October 2026, AUSTRAX HLDGS (02680.HK) expected an interim loss and comprehensive expense of HK$4.8-5.9 million, against a HK$18.3 million profit.
On 16 October 2026, CHINARES PHARMA (03320.HK) announced its wholly-owned subsidiary completed the RMB 900 million second tranche of its 2026 corporate bonds.
On 16 October 2026, DOBOT (02432.HK) said the trustee of its H Share Incentive Scheme bought 99,800 H shares on 15-16 October for about HKD 1,670,696.
On 16 October 2026, CHINARES PHARMA (03320.HK) began a pre-bid process at CBEX for a new share issue by its non-wholly-owned unit CR Pharmaceutical Commercial.
On 16 October 2026, CHI MER LAND (00978.HK) said it will acquire the remaining 50% of Foshan Yiyun Real Estate for a net consideration of RMB 114.89 million.
On 16 October 2026, ESTUN (02715.HK) said Wu Kan ceased as acting CFO and Zhu Zhangxing was appointed chief financial officer, both from 16 October 2026.
On 16 October 2026, ZIBUYU (02420.HK) clarified its Amazon DSP advertising contract renews once only for a fixed year, giving a maximum term of two years.
On 16 October 2026, INNOSCIENCE (02577.HK) said its trustee bought 2.25m H shares under the 2025 Share Award Scheme from 8 July to 16 October at HK$45.02 each.
On 16 October 2026, LUFAX (06623.HK) warned of a net loss of RMB1.3-1.7 billion for Q3 2026, after a RMB694 million H1 loss, on credit losses and extra tax.
On 16 October 2026, LINMON MEDIA (09857.HK) said its drama "A Small Town Remedy" will premiere on CCTV-8 on 21 October 2026 and stream exclusively on iQIYI.
